Cardiology

Leadless pacemakers may soon be available for all patients

Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam UMC, an improved version ...

Diseases, Conditions, Syndromes

High demand for at-home COVID tests could hamper supply

(HealthDay)—Demand for Abbott Laboratories' at-home COVID-19 tests has reached "unprecedented" levels and supply may be limited in the coming weeks, the company says.

page 1 from 5